SPAG6 and myelodysplastic syndrome: In hematological malignancy, SPAG6 expression was found to be elevated in patients with MDS than in healthy patients and could regulate the proliferation, cell cycle, and apoptosis of MDS cells (Bao et al., 2022; Jiang et al., 2019; Mu et al., 2022).